Comparison of short-term changes in right ventricular function after catheter-directed thrombolysis-based therapy <i>vs.</i> anticoagulation alone in acute intermediate-risk pulmonary embolism.

J Thorac Dis · 2026 · PMC12972923 · PMID 41816459

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

showed a trendP=0.09so close (0.05 < p ≤ 0.1)

In addition, Qanadli score, NT-proBNP, and troponin T showed a trend of being higher in the CDT plus anticoagulation group than in the anticoagulation group [42.50% (IQR, 35.00%, 50.00%) vs. 36.25% (IQR, 24.38%, 48.12%), P=0.09; 2,036.30 (IQR, 802.50, 3,984.00) vs. 1,033.45 (IQR, 379.75, 2,459.80) ng/L, P=0.07; 42.40 (IQR, 19.00, 68.00) vs. 23.31 (IQR, 9.28, 67.25) ng/L, P=0.07, respectively].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Comparison of short-term changes in right ventricular function after catheter-directed thrombolysis-based therapy &lt;i&gt;vs.&lt;/i&gt; anticoagulation alone in acute intermediate-risk pulmonary embolism.

The sentences

Comparison of short-term changes in right ventricular function after catheter-directed thrombolysis-based therapy <i>vs.</i> anticoagulation alone in acute intermediate-risk pulmonary embolism.